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Abstract
Plasmodium falciparum infection during pregnancy causes maternal anemia and low birth weight 
(LBW), but the effect of frequency and timing of infection on the severity of these adverse effects 
is unknown. We conducted a cohort study recruiting 2462 pregnant women in Malawi. Microscopy 
was used to diagnose malaria at enrollment, follow-up and delivery. Birth weight and maternal 
hemoglobin were measured at delivery. The association between timing and frequency of infection 
and LBW and maternal anemia was analyzed using a binomial regression model. Compared with 
uninfected women, (i) the risk of LBW increased with the number of malaria episodes [one 
episode: prevalence ratio (PR) 1.62 (95% CI 1.07–2.46); two episodes: PR 2.41 (95% CI 1.39–
4.18)]; (ii) the risk for maternal anemia increased with the number of malaria episodes [one 
episode: PR 1.15 (95% CI 0.86–1.54); two episodes: PR 1.82 (95% CI 1.28–2.62)]; and (iii) the 
risk of LBW was higher with infection in the second (PR 1.71; 95% CI 1.06–2.74) than third 
trimester or at delivery (PR 1.55; 95% CI 0.88–2.75). The timing and frequency of P. falciparum 
infection during pregnancy affected the risk of LBW but only frequency of infection had an effect 
on the risk of maternal anemia. Identification of gestational periods when malaria causes most 
adverse outcomes will facilitate effective targeting of interventions.
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1. Introduction
Each year more than 50 million pregnant women in areas endemic for Plasmodium 
falciparum infection are at risk of its complications [1], which are dependent on 
transmission rates and levels of acquired immunity. In low transmission areas, complications 
include anemia, severe malaria [2,3], and problems of pregnancy such as spontaneous 
abortions, still births and low birth weight (LBW). In high transmission areas, women of 
reproductive age have acquired partial immunity to malaria [4]. Consequently, they are not at 
risk for severe disease, but are at an increased risk for developing anemia and delivering 
babies with LBW. The actual mechanisms by which P. falciparum infection during 
pregnancy causes LBW and anemia still remain unclear. Multiple factors have been cited as 
contributing to the pathophysiology of LBW [5–10] and maternal anemia [11–13], but the 
role of each of these factors has not been elucidated clearly.
To our knowledge, there have been very few studies that have investigated the effect of 
frequency of P. falciparum infection during pregnancy on the risk of LBW and maternal 
anemia [14]. Some studies that have examined the relationship between timing of malaria 
infection during pregnancy and the risk for complications have used placental histology to 
draw inferences regarding the evolution of infection during pregnancy [4,7,15–21]. The 
assessment of malaria at a single time point may result in misclassification of the exposure 
to malaria during pregnancy. Other studies have limited recruitment to primigravidae [22]. 
Plasmodium falciparum infection in multigravidae is not infrequent, and also poses a 
significant risk for severe anemia and LBW [18].
We therefore conducted a prospective study to examine women for the presence of 
parasitemia at several time points during pregnancy and at delivery to investigate the impact 
of timing and frequency of P. falciparum malaria on the risk of LBW and maternal anemia. 
This information could aid policy makers to identify the crucial time point when treatment 
and intermittent presumptive therapy (IPTp) would be most effective in preventing the 
complications of infection of malaria during pregnancy.
2. Methods
2.1. Study site
The study was conducted at Mpemba and Madziabango health centers in Blantyre District, 
which has a population of approximately 950 000 [23] and is located in the southern region 
of Malawi. Malaria transmission is perennial peaking during the rainy season (November–
March). Plasmodium falciparum causes over 90% of all malaria infections. The two health 
centers have maternity beds for delivery of low risk pregnancies, a malaria microscopy 
laboratory with a trained medical technologist, and four full-time and nine part-time nurses. 
There are 18 traditional birth attendants (TBAs) who attend births in the community. Women 
Kalilani et al. Page 2













with high risk pregnancies are referred to a tertiary hospital located approximately 10 km 
away for management.
2.2. Study population and recruitment
All pregnant women attending routine antenatal care at the two health facilities were invited 
to participate in the study. A total of 2462 women were recruited between April 2002 and 
July 2003. Signed or witnessed verbal consent was sought for participation in the study 
before enrollment. A standardized questionnaire was used to obtain information on 
demographics, past obstetric history, malaria symptoms, and factors associated with malaria 
prevention measures such as use of insecticide-treated bed nets (ITNs) and antimalarial 
drugs in pregnancy. Study participants were given study numbers to retain until delivery for 
easy identification.
At enrollment, women received routine antenatal assessment, which included height, weight, 
temperature and blood pressure measurements, and abdominal examination. A sample of 
venous blood was collected for estimation of hemoglobin concentration and preparation of 
thick blood films. The women were given a dose of sulfadoxine-pyrimethamine (SP) as IPTp 
under direct observation by the antenatal clinic personnel. Antenatal records were checked 
to ensure that SP was not given at intervals of less than 1 month.
2.3. Follow-up
The follow-up visits were scheduled according to standard antenatal routine care. Depending 
on the gestation age at enrollment, women were seen at approximately the following 
gestational ages: 12, 26, 32 and 36–38 weeks, and at delivery. At these visits, women 
received routine antenatal care and a standardized interview was conducted to obtain 
information on malarial illnesses and use of antimalarial drugs between visits. A peripheral 
blood sample was obtained for preparation of thick films, and the women were given a 
second dose of SP according to the Malawi national policy schedule. The women were 
encouraged to deliver at the health centers.
2.4. Delivery
Blood samples were obtained soon after delivery for measurement of maternal hemoglobin 
concentration and examination of peripheral, placental and cord thick films. Newborns 
delivered at the health centers were weighed within 24 h of delivery using a digital scale. A 
system was set up such that community nurses and TBAs were able to identify study 
participants who delivered at home. The TBAs were trained to prepare peripheral, placental 
and cord thick films from these women, and to forward them to the clinics through 
community health workers. Newborns delivered in the community were weighed using 
color-coded scales that indicated green if the newborn weighed 2500 g or more and red if the 
newborn weighed less than 2500 g.
2.5. Laboratory methods
Malaria diagnosis was performed using microscopy of Giemsa-stained thick blood films. 
Parasite densities were estimated using an assumed leukocyte count of 6000 leukocytes/μl of 
blood. A thick film was considered negative if no parasites were detected after examining 
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100 microscopic fields each containing approximately 20 white blood cells. All thick films 
were read by two skilled microscopists and any discrepancies (positive vs. negative or more 
than 25% difference in parasite density) were resolved by repeating the readings. 
Hemoglobin concentration was determined using a HemoCue machine (HemoCue 
Incorporated, Angelholm, Sweden).
2.6. Outcome definitions
Newborns were classified as having normal birth weight (≥2500 g) or LBW (<2500 g), 
regardless of gestational age. Anemia was defined as maternal hemoglobin concentration 
<11 g/dl [24]. Anemia was further classified into mild anemia (9–10.9 g/dl), moderate 
anemia (7–8.9 g/dl) and severe anemia (<7 g/dl).
2.7. Statistical analysis
Data analysis was performed using STATA version 9.0 software (Stata Corp., College 
Station, TX, USA). Comparison of baseline demographic characteristics was performed 
using the χ2 test for categorical data, t-test for normally distributed and Mann-Whitney test 
for non-normally distributed continuous variables. The frequency of malaria infection was 
classified according to the number of episodes detected during the study clinic visits during 
pregnancy. The timing of malaria infection was defined as: (1) parasitemia in the second 
trimester (gestation age 13–26 weeks), and (2) parasitemia in the third trimester or at 
delivery (gestation age >26 weeks to term). Only nine women presented for first trimester 
antenatal care, and these women were therefore excluded from the analysis.
Multivariate analyses were performed using a binomial regression model to estimate the 
association between timing and frequency of P. falciparum infection during pregnancy and 
LBW or maternal anemia. The analysis was stratified by the total number of visits during 
follow-up. Effect measure modification was assessed by including an interaction term and 
using the log-likelihood test at an α-level of 0.10. Confounding was assessed using the 
change in estimate criteria. Variables were considered confounders if there was an absolute 
change in estimate of 0.10. A backward elimination strategy was used to identify the best 
model. Covariates that were considered as potential confounders included maternal age, 
body mass index (BMI), gravidity and use of ITNs. All P-values are two-sided, and CIs were 
calculated at the 95% level. Statistical significance was set at P ≤ 0.05.
3. Results
3.1. Study population
Of the 2462 women enrolled into the study, birth weight was recorded for 1548 newborns 
and information on hemoglobin concentration at delivery was available for 1253 women. 
Data was missing for women who had moved or delivered outside the study area, or failed to 
return for follow-up and could not be found by the study team. Women who are included in 
this analysis and those lost to follow-up are compared in Supplementary Table 1. Only 
women who were enrolled into the study at their first antenatal visit were included in this 
analysis; 1172 women with information on birth weight (n = 1162) and/or hemoglobin 
concentration at delivery (n = 973) (Figure 1). The characteristics of these women are shown 
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in Table 1. The mean maternal age was 23.8 (SD 5.6) years, the mean gestation age at 
enrollment was 23.9 (SD 3.7) weeks, 15.3% of the women reported owning ITNs and the 
total number of visits per woman were: two [38.4%, (n = 451)], three [52.1% (n = 610)] and 
four [9.5% (n = 111)].
3.2. Prevalence of malaria
The overall prevalence of parasitemia at enrollment was 20.1% (n = 235) and significantly 
higher in primigravidae than multigravidae [41.2% vs. 12.2%; prevalence ratio (PR) 3.36; 
95% CI 2.69–4.21]. The cumulative prevalence of parasitemia throughout pregnancy was 
also higher in primigravidae than multigravidae (56.2% vs. 22.8%; PR 2.46; 95% CI 2.10–
2.88). More women had parasitemia during the antenatal visits than at delivery irrespective 
of gravidity [19.1% (n = 222) vs. 7.2% (n = 84); P < 0.001], and 5.3% (n = 62) of the 
women had parasitemia both in the antenatal period and at delivery (Supplementary Table 
2).
3.3. Risk factors for low birth weight
The mean birth weight was 3018.2 g (SD 482.3 g), and the prevalence of LBW was 9.3% (n 
= 108). Gravidity, maternal age, use of ITNs and the presence of maternal anemia at delivery 
were significantly associated with LBW in bivariate analyses. Women had an increased risk 
of delivering a LBW baby if they were primigravidae (16.5% vs. 6.8%; PR 2.42; 95% CI 
1.70–3.45), were less than 20 years old (14.8% vs. 7.5%; PR 1.99; 95% CI 1.38–2.86), had 
anemia at delivery (12.8% vs. 7.9%; PR 1.61; 95% CI 1.06–2.46) and if they were not using 
ITNs (10.1% vs. 5.2%; PR 1.96; 95% 1.01–3.80). After adjustment for other baseline 
characteristics, only gravidity was still significantly associated with the risk of LBW; the 
risk was higher among primigravidae than multigravidae (PR 2.78; 95% CI 1.60–4.79).
3.4. Risk factors for maternal anemia
The prevalence of mild, moderate and severe anemia at enrollment was 52.8% (n = 616), 
13.6% (n = 159) and 1.3% (n = 15), respectively. The prevalence of mild, moderate and 
severe anemia at delivery was 19.4% (n = 189), 3.1% (n = 30) and 0.1% (n = 1) respectively. 
Although not statistically significant, in bivariate analyses, the risk of anemia at delivery was 
higher in primigravidae than multigravidae (25.9% vs. 21.3%; PR 1.17; 95% CI 0.91–1.49), 
women less than 20 years old (25.5% vs. 21.8%; PR 1.20; 95% CI 0.94–1.52), women who 
had malaria during pregnancy (26.0% vs. 21.0%; PR 1.20; 95% CI 0.98–1.47) and in women 
who had their first antenatal clinic visit in the third trimester vs. the second trimester of 
pregnancy (30.9% vs. 22.1%; PR 1.40; 95% CI 0.93–2.12). The risk of maternal anemia at 
delivery was lower in women who received two doses (18.2% vs. 28.2%; PR 0.64; 95% CI 
0.50–0.82) or three doses (25.8% vs. 28.2%; PR 0.92; 95% CI 0.63–1.34) compared with 
one dose of SP as IPTp. None of the variables were statistically significantly associated with 
anemia at delivery after adjustment for other baseline characteristics.
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3.5. The effect of frequency of Plasmodium falciparum infection on low birth weight and 
maternal anemia
Compared with women who had no malaria, the prevalence of LBW increased with the 
number of episodes detected during pregnancy [one episode (13.0% vs. 7.0%; PR 1.62; 95% 
CI 1.07–2.46) and two episodes (21.4% vs. 7.0%; PR 2.41; 95% CI 1.39–4.18)], adjusting 
for maternal age, gravidity, BMI, total number of visits and use of ITNs. This effect was 
seen both in primigravidae and multigravidae.
The risk of maternal anemia at delivery also increased with the number of episodes of 
infection detected during pregnancy [one episode (23.4% vs. 21.2%; PR 1.15; 95% CI 0.86–
1.54) and two episodes (36.4% vs. 21.2%; PR 1.82; 95% CI 1.28–2.62)], after adjusting for 
maternal age, gravidity, BMI, total number of visits and the use of ITNs. Additionally, the 
risk of maternal anemia at delivery was significantly higher in women who had two or more 
episodes of malaria detected compared with women who had one detected episode of 
malaria (PR 1.58; 95% CI 1.08–2.33) (Table 2).
3.6. The effect of timing of malaria infection on low birth weight and maternal anemia
The risk of LBW also varied with the timing of the infection during pregnancy. Compared 
with women who had no infection during pregnancy, the risk of LBW was higher in women 
who had infection detected in the second trimester only (PR 1.71; 95% CI 1.06–2.74) than in 
women who had infection detected during the third trimester or at delivery (PR 1.55; 95% 
CI 0.88–2.75).
There was no significant difference in the risk of maternal anemia at delivery in women who 
had parasitemia detected in the second trimester only (PR 1.19; 95% CI 0.83–1.71) or third 
trimester only (PR 1.12; 95% CI 0.75–1.66) compared with women who no parasitemia after 
adjusting for other baseline characteristics (Table 3).
4. Discussion
In a large sample of pregnant women in Malawi, we found that the risk of LBW and 
maternal anemia increased with the number of episodes of infection detected during 
pregnancy, irrespective of gravidity. Timing of infection also affected the risk of LBW. 
Second trimester infection increased the risk of LBW more than infection detected in third 
trimester or at delivery.
Plasmodium falciparum infection during pregnancy is characterized by the sequestration of 
infected erythrocytes in the maternal placental vascular space [25]. Studies have shown that 
this sequestration causes an infiltration of inflammatory cells and elevation of cytokine 
levels in the infected placenta [9,10,26]. It has been suggested that this inflammatory 
response reduces the materno-fetal exchange of nutrients across the placenta, leading to 
growth restriction in the fetus. This might also be exacerbated by depletion of nutrients by 
the growing parasites or by white cells infiltrating the blood spaces of the placenta, and by 
mechanical blockage due to thickening of the basement membrane [7–10]. We found that the 
risk of LBW increased with the number of episodes experienced during pregnancy. This 
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suggests that the damage caused to the placenta by the sequestration of malaria parasites is 
cumulative.
Timing of infection during pregnancy affected the risk of LBW, which was higher in women 
with infection early in pregnancy than infection detected late in pregnancy. Maximum fetal 
growth occurs between 20 and 28 week gestation, this would explain why infection in the 
second trimester increased the risk of LBW more than infection in the third trimester. Other 
studies have also suggested that timing of infection determines the risk of adverse outcomes. 
A study conducted in Malawi found that infection early in pregnancy was associated with 
intrauterine growth retardation while infection late in pregnancy was associated with preterm 
delivery [22]. Another study conducted in Burkina Faso found that the risk of LBW was 
higher after 6 months gestation [14]. Other studies have found that women with infections 
early in pregnancy did not show histological changes seen in infected placentae at delivery 
[8,27], indicating that there is resolution of histopathological changes after clearance of 
parasites in the placenta.
We did not find a significant difference in the risk of maternal anemia at delivery between 
women who had no parasitemia and those with parasitemia detected in the second or third 
trimester of pregnancy. However, the risk of maternal anemia also increased with the number 
of episodes of infection detected during pregnancy both in primigravidae and multigravidae. 
Compared with women who had no infection during pregnancy, the mean hemoglobin 
concentration was 0.3 g/dl lower in women who had one episode, and 0.6 g/dl lower in 
women with two or more episodes of malaria infection detected during pregnancy. The 
increased risk of developing maternal anemia with repeated infections may be particularly 
relevant in countries like Malawi where there are high rates of co-morbidities including HIV, 
hookworm infection and nutritional deficiencies [28].
Determining the precise period during pregnancy when malaria infection causes most harm 
has important public health implications. Most malaria-endemic areas have limited resources 
and most women do not receive the recommended two doses of SP during pregnancy due to 
limited access to health facilities, lack of drugs and poor seeking behavior [29,30]. Targeting 
interventions to the period when malaria causes the most damage can ensure optimal 
pregnancy outcomes in resource constrained settings.
There were several limitations in our study. We did not obtain information on HIV infection, 
which is associated with an increased risk of infection with malaria and its complications, 
and this could potentially have biased our results. Because only nine women presented 
during their first trimester of pregnancy in our study, consistent with other observations from 
women in rural areas of Malawi [31], we were unable to investigate the impact of malaria 
infection during the first trimester of pregnancy. Despite extensive attempts at follow-up 
including using TBAs to collect samples from home deliveries, loss to follow-up was 
common and occurred in part because of the highly mobile nature of this peri-urban study 
population. Women who were lost to follow-up were younger, primigravidae and were less 
likely to own ITNs. They were therefore more at risk of having malaria and would have 
potentially increased the effect seen in our cohort.
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Future research studies could improve the identification of malaria at delivery by including 
the examination of placental histology. Recruiting women in the first trimester of pregnancy 
could aid our understanding of the impact of malaria during embryogenesis. Fetal growth 
monitoring using more sensitive methods such as obstetric ultrasound would provide more 
information on when malaria causes LBW during pregnancy.
In conclusion, the frequency of malaria infection during pregnancy has an effect on the risk 
of LBW and maternal anemia. The risk of maternal anemia and LBW increased with the 
number of episodes of malaria experienced during pregnancy. Additionally, the timing of 
infection also had an effect on the risk of LBW, increasing when infection occurred early in 
pregnancy during the second trimester. There is a need to conduct more studies to identify 
the crucial time period during pregnancy when malaria infection causes the greatest impact 
in order to target interventions to improve the effectiveness of malaria prevention strategies 
in pregnancy.
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The flow of study participants from enrollment to delivery.
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Table 1
Baseline characteristics of the women enrolled into the study
Baseline characteristic All women (n = 1172) Malaria positivea (n = 372) Malaria negativeb (n = 800) P-value
Age (years) 23.8 ± 5.6 22.3 ± 5.2 24.6 ± 5.7 <0.01
Gravidity
 Primigravidae 306 (26.3) 172 (46.7) 134 (16.8) <0.01
 Multigravidae 858 (73.7) 196 (53.3) 662 (83.2)
Bed net usage 176 (15.3) 46 (12.5) 130 (16.7) NS
Gestation age (weeks) 23.9 ± 3.7 23.2 ± 3.8 24.2 ± 3.7 <0.01
Body mass index (kg/m2) 21.6 ± 2.4 21.3 ± 2.4 21.7 ± 2.4 0.02
Hemoglobin (g/dl) 10.2 ± 1.4 9.9 ± 1.4 10.3 ± 1.3 <0.01
Maternal anemiac 790 (67.4) 266 (71.9) 524 (65.8) 0.04
Routine SP treatment ≥2 doses 720 (61.4) 263 (70.7) 457 (57.1) <0.01
Total number of visits
 2 451 (38.4) 109 (29.3) 342 (42.8) <0.01
 3 610 (52.1) 209 (56.2) 401 (50.1)
 4 111 (9.5) 54 (14.5) 57 (7.1)
Data are mean ± SD or number (%); SP: sulfadoxine-pyrimethamine; NS: not significant.
a
Women who had at least one episode of P. falciparum infection detected during pregnancy or at delivery
b
Women who had no P. falciparum infection detected during pregnancy or at delivery
c
Anemia was defined as a hemoglobin concentration <11 g/dl.
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